Delivery Order SPE2DB22D2005-SPE2DB24FJLE3
Award Date 4/12/24
Potential Completion Date 4/15/24
Potential Value $19K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $1,041.32 to provide 4,564,171,744 units of the pharmaceutical product Advair HFA 115-21 MCG Inhaler 12GM. The contract has an ultimate completion date of April 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,562.04 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide Advair HFA 115-21 MCG inhalers. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that was previously awarded to Amerisourcebergen Drug Corp by DLA for the provision of a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 45-21 mcg inhalers. The $2,706.60 contract has an ultimate completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,029,522 units of the pharmaceutical product Advair HFA 230-21 MCG Inhaler 12GM. The award, with a ceiling value of $1,422.58, has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and operates under an indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $1,524.46 to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 mcg inhaler, 12 gm. This order, which has an ultimate completion date of October 11, 2024, is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. The IDC, held by AmerisourceBergen, enables the DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,862.36 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of Advair HFA 230-21 MCG inhalers to support military treatment programs and facilities. The delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of pharmaceutical products. Specifically, the contract is for the delivery of Advair HFA 230-21 MCG inhalers, with a ceiling value of $10,761.84 and a period of performance through April 4, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a specialty pharmaceutical product - Advair HFA 115-21 MCG Inhaler 12GM. The contract has a ceiling value of $3,670.08 and an ultimate completion date of March 18, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Advair HFA 45-21 mcg inhaler 12g. The award, valued at $2,546.04, has an ultimate completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC...
- The Defense Logistics Agency (DLA) awarded a $4,866.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,248,106 units of the Advair HFA 115-21 MCG inhaler (12 gram). This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA Troop Support Medical, valued at up to $999,999,999.00 and effective through December 31, 2025. The IDC serves as the...